AdvaMed® Advancements: Q2 2026 Report
Explore AdvaMed’s Q2 2026 Report to see how advocacy, member engagement, and policy progress are advancing innovation and strengthening the medtech industry.
AdvaMed Advancements
AdvaMed Earns WTOP News Regional Top Workplaces 2026 Award, Culture Excellence Awards
Washington, D.C.—AdvaMed, the largest trade association representing medtech innovators, announced today it is a WTOP News Top Workplaces 2026 award winner in the Washington, D.C., region and received five Culture…
AdvaMed® Advancements: Q1 2026 Report
Explore AdvaMed®’s Q1 2026 report on medtech policy, regulatory trends, reimbursement, and advocacy driving innovation and patient access.
2025 Annual Report
Explore AdvaMed®’s key achievements and milestones in 2025 on behalf of our member companies and the patients they serve.
AdvaMed® Plays Tariff Chess, Trump Plays Checkers
As tariff uncertainty continues in 2025,AdvaMed® plays tariff chess, advocating for predictable, zero-for-zero policies to protect medtech innovation and access.
AdvaMed® Advancements: Q4 2025 Report
AdvaMed® Advancements: Q4 2025 Report highlights how unified industry advocacy responded to policy disruption, trade uncertainty, and federal action impacting medtech.
AdvaMed® Advancements: Q3 2025 Report
AdvaMed® Advancements: Q3 2025 Report. Amid an increasingly charged political environment,AdvaMed® remained a steady, persuasive voice for medtech innovation. From mobilizing rapid action on the Section 232 investigation to advancing…
AdvaMed® Advancements: Q2 2025 Report
Discover our Q2 report highlighting key industry wins, tariff updates, and strategic progress driving medtech innovation and advocacy forward.
2024 Annual Report
Explore AdvaMed®’s key achievements and milestones in 2024 on behalf of our member companies and the patients they serve.
AdvaMed® Advancements: Q3 2024 Report
AdvaMed® Advancements: Q3 2024 Report is proud to showcase the significant achievements we accomplished in Q3 of 2024.